ADVANCED PRECLINICAL DEVELOPMENT AND PRODUCTION OF MASTER SEE VIRUS OF GEO-LM01, A NOVEL MVA-VLP VACCINE AGAINST LASSA FEVER
$2,442,307FY2018Defense Health AgencyDOD
Geovax, Inc., Smyrna GA
Investigators
View source on USAspending →ADVANCED PRECLINICAL DEVELOPMENT AND PRODUCTION OF MASTER SEE VIRUS OF GEO-LM01, A NOVEL MVA-VLP VACCINE AGAINST LASSA FEVER · GrantIndex